CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


WJ-MSCsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug463 COVID-19 Pneumonia Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D007239 Infection NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells

The purpose of this study is to investigate the potential use of Wharton's Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus SARS-CoV-2 infection, and showing symptoms of COVID-19.

NCT04313322 Use of Stem Cells for COVID-19 Treatment Biological: WJ-MSCs

Primary Outcomes

Description: Improvement of clinical symptoms including duration of fever, respiratory destress, pneumonia, cough, sneezing, diarrhea.

Measure: Clinical outcome

Time: 3 weeks

Description: Side effects measured by Chest Readiograph

Measure: CT Scan

Time: 3 weeks

Description: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative

Measure: RT-PCR results

Time: 3 weeks

Secondary Outcomes

Description: Results of Real-Time Polymerase Chain Reaction of Viral RNA, Turing negative

Measure: RT-PCR results

Time: 8 weeks


No related HPO nodes (Using clinical trials)